NCT03588390View on ClinicalTrials.gov

This Study in Healthy Men Tests How Different Doses of BI 1323495 Are Taken up in the Body and How Well They Are Tolerated.

PHASE1CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

July 31, 2018

Primary Completion Date

November 14, 2018

Study Completion Date

November 14, 2018

Conditions
Healthy
Interventions
DRUG

BI 1323495

Low strength tablet

DRUG

BI 1323495

Middle strength tablet

DRUG

BI 1323495

High strength tablet

DRUG

Placebo

Placebo to low strength tablet

DRUG

Placebo

Placebo to middle strength tablet

DRUG

Placebo

Placebo to high strength tablet

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT03588390 - This Study in Healthy Men Tests How Different Doses of BI 1323495 Are Taken up in the Body and How Well They Are Tolerated. | Biotech Hunter | Biotech Hunter